Literature DB >> 11831862

Acute intermittent porphyria: heterogeneity of mutations in the hydroxymethylbilane synthase gene in Italy.

F Martinez di Montemuros1, E Di Pierro, G Biolcati, E Rocchi, E Bissolotti, D Tavazzi, G Fiorelli, M D Cappellini.   

Abstract

Acute intermittent porphyria (AIP) is an autosomal disorder caused by molecular abnormalities in the gene coding for hydroxymethylbilane synthase (HMBS), the third enzyme in the heme biosynthetic pathway. So far, more than 170 different mutations responsible for AIP have been identified worldwide in the HMBS gene. In this study we have performed molecular characterization in 14 patients with suspected diagnosis of AIP and in 29 family members of Italian ancestry. Molecular analysis of the HMBS gene allowed us to identify 13 different mutations among 14 patients with reduced HMBS activity: 5 splicing defects (IVS9+22 G>A, 612 G>T, IVS11-2 delA, IVS12+2 T>C, and IVS13-1 G>A), 1 small insertion (182 insGA), 1 small deletion (730-731 delCT), and 6 missense/nonsense mutations (76 C>T, 295 G>A, 331 G>A, 580 C>T, 673 C>T, and 874 C>T), resulting in single-amino-acid substitutions or protein truncations. Six of these molecular abnormalities had already been described and 7 are new findings. In a previous work on an Italian population we detected 7 different mutations among 8 AIP patients. This study has raised to 18 the number of different mutations so far found among the Italian AIP population, 11 of which are new findings. We can conclude that the mutation screening in the Italian population contributes to improvement of the diagnostic approach of AIP and to establishing possible clustering of mutations in the Mediterranean area. Copyright 2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11831862     DOI: 10.1006/bcmd.2001.0466

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  6 in total

1.  Pro-oxidant and antioxidant factors in acute intermittent porphyria: family studies.

Authors:  E Rocchi; P Ventura; A Ronzoni; M C Rosa; C Gozzi; L Marri; G Casalgrandi; M D Cappellini
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

Review 2.  Porphyrias at a glance: diagnosis and treatment.

Authors:  Maria Domenica Cappellini; Valentina Brancaleoni; Giovanna Graziadei; Dario Tavazzi; Elena Di Pierro
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

3.  The porphyrias: pathophysiology.

Authors:  Antonello Pietrangelo
Journal:  Intern Emerg Med       Date:  2010-10       Impact factor: 3.397

4.  Diagnosis of feline acute intermittent porphyria presenting with erythrodontia requires molecular analyses.

Authors:  Sonia Clavero; Yuri Ahuja; David F Bishop; Brittany Kwait; Mark E Haskins; Urs Giger; Robert J Desnick
Journal:  Vet J       Date:  2013-10-10       Impact factor: 2.688

5.  CRISPR/Cas9 mediated β-globin gene knockout in rabbits recapitulates human β-thalassemia.

Authors:  Yi Yang; Xiangjin Kang; Shiqi Hu; Bangzhu Chen; Yingjun Xie; Bing Song; Quanjun Zhang; Han Wu; Zhanhui Ou; Yexing Xian; Yong Fan; Xiaoping Li; Liangxue Lai; Xiaofang Sun
Journal:  J Biol Chem       Date:  2021-02-24       Impact factor: 5.157

6.  Molecular Analysis of 55 Spanish Patients with Acute Intermittent Porphyria.

Authors:  María-José Morán-Jiménez; María-José Borrero-Corte; Fátima Jara-Rubio; Inmaculada García-Pastor; Silvia Díaz-Díaz; Francisco-Javier Castelbón-Fernandez; Rafael Enríquez-de-Salamanca; Manuel Méndez
Journal:  Genes (Basel)       Date:  2020-08-12       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.